Lenovo Announces New Innovations in Gaming, Software, Visuals, and Accessories for the Holidays
Today, Lenovo announced several new products and solutions at its annual holiday product launch. The new additions to the portfolio – which include AI-tuned innovations in gaming, a groundbreaking 3D monitor, software solutions, versatile accessories, and more – are available to explore here.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230831307965/en/
Lenovo Announces New Innovations in Gaming, Software, Visuals, and Accessories for the Holidays (Photo: Business Wire)
Gaming on the Go: Lenovo Legion™ Gaming Handheld Device and Accessories Untether PC Gaming
The new Lenovo Legion Go is the company’s first Windows gaming handheld device that gives gamers more freedom to game however—and wherever—they want. The Lenovo Legion Go is designed for gamers who will settle for nothing less than top-tier specs and visuals on their handheld device. Along with the new micro-OLED-equipped Lenovo Legion Glasses and new Lenovo Legion E510 7.1 RGB Gaming In-Ear Headphones, the debut of the Lenovo Legion Go is a marked expansion of the Lenovo Legion ecosystem of gaming devices, monitors, accessories, software, and services that empower gamers to immerse themselves in their games.
- The new Lenovo Legion Go brings Windows PC gaming power to a handheld mobile form factor, powered by AMD Ryzen™ Z1 Series processors that bring games to life on its 8.8-inch Lenovo PureSight Gaming Display.
- For gamers who want to take their Lenovo Legion Go portable gaming experience to the next level, the new Lenovo Legion Glasses leverage micro-OLED technology to provide a large screen viewing experience that fits in the pocket.
- For a truly immersive gaming experience, the new Lenovo Legion E510 7.1 RGB Gaming In-Ear Headphones offer hi-res 7.1 surround sound audio with a multifunction inline controller.
The King of Cool: Lenovo Legion 9i is the World’s First AI-Tuned Gaming Laptop with an Integrated Liquid-Cooling System1
The Lenovo Legion 9i (16”, 8) is the first top-of-the-line 16-inch gaming laptop in Lenovo Legion’s ecosystem—and in the world—with a self-contained liquid-cooling system1, designed for gamers and creators with heavy graphic workflow requirements who need a full development studio in their bag. The Lenovo Legion 9i leads the Lenovo Legion lineup that also includes the Lenovo Legion Pro series for competitive gamers and the Lenovo Legion Slim series for gamers who value agility, as well as Lenovo Legion displays and peripherals. Also announced today are the Lenovo Legion 16” Gaming Backpack GB700 and GB400, two backpack options that give gamers a choice between slim and lightweight agility or extra storage without sacrificing protection for their Lenovo Legion 9i (16”, 8) or any other laptops and accessories.
Transforming Digital Workspaces: New Devices and Software Power the Future of Hybrid Work
In addition to new gaming devices, Lenovo is unveiling new cutting-edge tech tools and essentials tailored to empower the dynamic, evolving needs of today's business end-users. Its new monitor, software, and accessories are not only designed to boost the capabilities of today’s remote and hybrid workforces, but also to address significant challenges faced by businesses as they digitize operations across departments. Lenovo research shows that managing a remote workforce and global teams remain central tasks for CIOs.2 That’s why the new offerings integrate impressive processing power, immersive 3D, and advanced security to create a unified, human-centered experience.
- For professional content creators who require immersive 3D visualization, the new ThinkVision™ 27 3D Monitor – a stunning 27-inch, glasses-free, 2D/3D compatible monitor – offers seamless 3D effects and real-time eye-tracking.
- The new Lenovo Wired VOIP Headset and Lenovo Wired ANC Headset Gen 2 are high-quality audio solutions for professionals in hybrid work environments, include an inline call control box, active noise cancellation with the latter, and compatibility with popular conferencing platforms.
- For remote work and to support sustainability efforts, the cloud-based Lenovo Device Manager will roll out enhanced new features that include a comprehensive AI-powered energy management solution that efficiently manages device fleets and optimizes power usage.
- To round out the new line-up are a selection of sophisticated and comfortable carry cases, the Lenovo ThinkPad Professional 16inch Backpack Gen 2, and the ThinkPad Professional 16inch and 14inch Topload Gen 2.
For specific details on all the new products and solutions, see the various releases linked below and the press kit on Lenovo StoryHub.
- The King of Cool: Lenovo Introduces the Legion 9i, the World’s First AI-Tuned Gaming Laptop with Integrated Liquid-Cooling System
- Gaming on the Go: Lenovo Unveils a New Legion Gaming Handheld Device and Accessories that Untether PC Gaming
- Transforming Digital Workspaces: Lenovo Unveils New Devices and Software to Power the Future of Hybrid Work
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$62 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, employing 77,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into growth areas that fuel the advancement of ‘New IT’ technologies (client, edge, cloud, network, and intelligence) including server, storage, mobile, software, solutions, and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and smarter future for everyone, everywhere. To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
1Per an internal research conducted as of June 22, 2023, based on comparisons of gaming computers distributed by global PC manufacturers shipping > 1 million units worldwide annually, contained in a 16" panel size supported with a liquid cooling pump and does not have an external cooling attachment.
2 The Resilient CIO: Lenovo Global Study of CIOs 2023
LENOVO, LENOVO LEGION, and THINKVISION are trademarks of Lenovo. AMD and Ryzen are trademarks of Advanced Micro Devices. Inc. All other trademarks are the property of their respective owners. ©2023 Lenovo Group Limited
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230831307965/en/
Contact information
Wendy Fung, wfung@lenovo.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release
Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom